McGinley MP et al. Diagnosis and Treatment of MS: A Review. JAMA. 2021
IV methylprednisolone 1000 mg daily for 3 to 5 days for acute relapse
Lee SU et al. Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome. JAMA Neurology. 2024
IVIG and plasma exchange for Miller Fisher and related syndromes
Kennedy TA et al. ACR Appropriateness Criteria Orbits Vision and Visual Loss. JACR. 2018
Imaging guidance including MRI as first line for INO workup
Stroke and vascular references
Manrique LG et al. Mild Bilateral INO: Diagnostic Role of Vertical Posterior Canal VOR. J Neuro-Ophthalmology. 2022
vHIT role in detecting subtle bilateral INO in acute demyelination
Lee SU et al. INO Plus Ataxia Indicates Dorsomedial Tegmental Lesion. J Neurology. 2016
Anatomic correlates of INO with cerebellar signs
Hamza MM et al. INO Characterizes MS Rather Than NMOSD. J Neuro-Ophthalmology. 2022
INO more prevalent in MS than NMOSD; aids differential diagnosis
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.